It ain’t over ‘til it’s over and for Redx Pharma, it’s over. Redx and Jounce Therapeutics announced Monday morning that the two companies agreed to terminate their proposed business combination ...

For Redx Pharma Plc’s (AIM:REDX) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. REDX is ...

Jazz Pharmaceuticals has struck a deal to source two targeted cancer therapies from Redx Pharma. Redx will pocket $10 million upfront, with more to follow, in return for developing candidates against ...

A $425 million proposed marriage between Redx Pharma of the UK and Jounce Therapeutics is on the rocks, just over a month after it was first announced. Jounce has instead thrown its lot in with ...

Sam Waksal’s attempt to buy Redx Pharma has fallen apart. The failure of a company set up by the once-jailed biotech executive to close a deal led Redx to turn to Redmile for the cash to keep going ...

Shares in Redx Pharma were under pressure today following the announcement that it would not be advancing its cancer drug candidate RXC004 into phase 3 testing in biliary tract cancer, after it failed ...

There’s significant change on the way at Jounce Therapeutics. The embattled clinical-stage company announced Wednesday afternoon that it is laying off more than half of its workforce as part of a ...

Redx Pharma Plc (AIM:REDX), a pharmaceuticals company based in United Kingdom, led the AIM gainers with a relatively large price hike in the past couple of weeks. As a small cap stock, hardly covered ...

When a lead calls a real estate agent, REDX's Caller ID app shows relevant information like Lead Type, Name, Location and more. A new REDX mobile app turns callbacks into opportunities by syncing lead ...

Simply sign up to the UK companies myFT Digest -- delivered directly to your inbox. Trading of shares in Redx, a UK pharmaceuticals company, resumed after five months on Monday when the slimmed-down ...